Antibody-directed enzyme prodrug therapy (ADEPT)
- 1 January 1994
- journal article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 24-25 (1-3), 219-228
- https://doi.org/10.1007/bf02789232
Abstract
Antibody-directed enzyme prodrug therapy (ADEPT) has been studied in a human ovarian carcinoma xenograft grown subcutaneously in nude mice. Radioimmunoassay of supernatants obtained from tumor homogenates showed these to contain carcinoembryonic antigen (CEA). Biodistribution studies with125I-labeled monoclonal anti-CEA antibody, A5B7, and its F(ab′)2 fragment showed localization in these xenografts. The AB57-F(ab′)2 fragment conjugated to a bacterial enzyme, carboxypeptidase G2 (CPG2), and, radiolabeled with125iodine, also localized in the xenografts. The radiolabeled conjugate cleared from blood faster than the antibody alone. The percentage of injected dose per gram in tumor at 24 h postinjection was about fivefold lower than antibody alone. Tumor-to-blood ratio at 72 h after injection of the radiolabeled conjugate was 7 and the tumor-to-normal tissue ratios at this time point ranged from 20 (liver) to 75 (colon). A three-phase ADEPT antitumor study was carried out in which A5B7-F(ab′)2-CPG2 was allowed to localize and was followed by accelerated inactivation/clearance of blood CPG2 by a galactosylated anti-CPG2 antibody (SB43gal). A benzoic acid mustard-derived prodrug was injected 24 h after the conjugate, which led to growth delay in this tumor compared to the control untreated group. Further antitumor studies in this model are in progress.Keywords
This publication has 18 references indexed in Scilit:
- Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2Journal of Immunological Methods, 1993
- Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trialCell Biochemistry and Biophysics, 1992
- Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsEuropean Journal of Cancer and Clinical Oncology, 1991
- Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2Journal of Medicinal Chemistry, 1990
- Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.Proceedings of the National Academy of Sciences, 1988
- Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphataseThe British Journal of Radiology, 1986
- Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity methodEuropean Journal of Biochemistry, 1985
- Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection.Proceedings of the National Academy of Sciences, 1984
- Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.The Journal of Experimental Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981